Resolvyx Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2001-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://resolvyx.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Single and Multiple Ascending Oral Dose Study of RX-10001 in Healthy Volunteers
- First Posted Date
- 2009-07-17
- Last Posted Date
- 2009-12-02
- Lead Sponsor
- Resolvyx Pharmaceuticals, Inc
- Target Recruit Count
- 56
- Registration Number
- NCT00941018
- Locations
- 🇳🇱
PRA International, Zuidlaren, Netherlands
Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye
- First Posted Date
- 2008-12-01
- Last Posted Date
- 2010-09-24
- Lead Sponsor
- Resolvyx Pharmaceuticals, Inc
- Target Recruit Count
- 232
- Registration Number
- NCT00799552
- Locations
- 🇺🇸
ORA Clinical, Andover, Massachusetts, United States
News
No news found